This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swanson, P.
Right arrow Articles by Hackett, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swanson, P.
Right arrow Articles by Hackett, J., Jr.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 3860-3868, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.3860-3868.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

Priscilla Swanson,1 Carmen de Mendoza,2 Yagnya Joshi,3 Alan Golden,1 Richard L. Hodinka,3 Vincent Soriano,2 Sushil G. Devare,1 and John Hackett Jr.1*

Abbott Laboratories, AIDS Research and Retrovirus Discovery, Abbott Park, Illinois 60064,1 Instituto de Salud Carlos III, Service of Infectious Diseases, Madrid, Spain,2 Clinical Virology Laboratory, Children's Hospital of Philadelphia, and Departments of Pediatrics and Pathology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 191043

Received 11 October 2004/ Returned for modification 22 April 2005/ Accepted 6 May 2005

Human immunodeficiency virus type 1 (HIV-1) evolution and changing strain distribution present a challenge to nucleic acid-based assays. Reliable patient monitoring of viral loads requires the detection and accurate quantification of genetically diverse HIV-1. A panel of 97 HIV-1-seropositive plasma samples collected from Cameroon, Brazil, and South Africa was used to compare the performance of four commercially available HIV RNA quantitative tests: Abbott LCx HIV RNA Quantitative assay (LCx), Bayer Versant HIV-1 RNA 3.0 (bDNA), Roche AMPLICOR HIV-1 MONITOR v1.5 (Monitor v1.5), and bioMérieux NucliSens HIV-1 QT (NucliSens). The panel included group M, group O, and recombinant viruses based on sequence analysis of gag p24, pol integrase, and env gp41. The LCx HIV assay quantified viral RNA in 97 (100%) of the samples. In comparison, bDNA, Monitor v1.5, and NucliSens quantified viral RNA in 96.9%, 94.8%, and 88.6% of the samples, respectively. The two group O specimens were quantified only by the LCx HIV assay. Analysis of nucleotide mismatches at the primer/probe binding sites for Monitor v1.5, NucliSens, and LCx assays revealed that performance characteristics reflected differences in the level of genetic conservation within the target regions.


* Corresponding author. Mailing address: Abbott Laboratories, D-9NG, Bldg. AP20, 100 Abbott Park Road, Abbott Park, IL 60064-6015. Phone: (847) 938-0457. Fax: (847) 937-1401. E-mail: john.hackett{at}abbott.com.


Journal of Clinical Microbiology, August 2005, p. 3860-3868, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.3860-3868.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Scott, L. E., Noble, L. D., Moloi, J., Erasmus, L., Venter, W. D. F., Stevens, W. (2009). Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 Assays. J. Clin. Microbiol. 47: 2209-2217 [Abstract] [Full Text]  
  • Garrido, C., Zahonero, N., Corral, A., Arredondo, M., Soriano, V., de Mendoza, C. (2009). Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests. J. Clin. Microbiol. 47: 1031-1036 [Abstract] [Full Text]  
  • Oliver, A. R., Pereira, S. F., Clark, D. A. (2007). Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR Assay. J. Clin. Microbiol. 45: 3616-3619 [Abstract] [Full Text]  
  • Huang, S., Salituro, J., Tang, N., Luk, K.-C., Hackett, J. Jr, Swanson, P., Cloherty, G., Mak, W.-B., Robinson, J., Abravaya, K. (2007). Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Res 35: e101-e101 [Abstract] [Full Text]  
  • Drexler, J. F., de Souza Luna, L. K., Pedroso, C., Pedral-Sampaio, D. B., Queiroz, A. T. L., Brites, C., Netto, E. M., Drosten, C. (2007). Rates of and Reasons for Failure of Commercial Human Immunodeficiency Virus Type 1 Viral Load Assays in Brazil. J. Clin. Microbiol. 45: 2061-2063 [Abstract] [Full Text]  
  • Guan, M. (2007). Frequency, Causes, and New Challenges of Indeterminate Results in Western Blot Confirmatory Testing for Antibodies to Human Immunodeficiency Virus. CVI 14: 649-659 [Full Text]  
  • Foulongne, V., Montes, B., Didelot-Rousseau, M.-N., Segondy, M. (2006). Comparison of the LCx Human Immunodeficiency Virus (HIV) RNA Quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan Assays for Quantitation of HIV Type 1 RNA in Plasma.. J. Clin. Microbiol. 44: 2963-2966 [Abstract] [Full Text]  
  • Garcia-Diaz, A., Clewley, G. S., Booth, C. L., Labett, W., McAllister, N., Geretti, A. M. (2006). Comparative Evaluation of the Performance of the Abbott Real-Time Human Immunodeficiency Virus Type 1 (HIV-1) Assay for Measurement of HIV-1 Plasma Viral Load following Automated Specimen Preparation.. J. Clin. Microbiol. 44: 1788-1791 [Abstract] [Full Text]